A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

Ming Han; Alli Murugesan; Nizar J. Bahlis; Kevin Song; Darrell White; Christine Chen; Matthew D. Seftel; Kang Howsen-Jan; Donna Reece; Keith Stewart; Yagang Xie; Annette E. Hay; Lois Shepherd; Marina Djurfeldt; Liting Zhu; Ralph M. Meyer; Bingshu E. Chen; Tony Reiman

doi:10.1182/blood-2016-06-716902

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

Ming Han, Alli Murugesan, Nizar J. Bahlis, Kevin Song, Darrell White, Christine Chen, Matthew D. Seftel, Kang Howsen-Jan, Donna Reece, Keith Stewart, Yagang Xie, Annette E. Hay, Lois Shepherd, Marina Djurfeldt, Liting Zhu, Ralph M. Meyer, Bingshu E. Chen, Tony Reiman

Hematology/Oncology

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	732-735
Number of pages	4
Journal	Blood
Volume	128
Issue number	5
DOIs	https://doi.org/10.1182/blood-2016-06-716902
State	Published - Aug 4 2016

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2016-06-716902

Cite this

Han, M., Murugesan, A., Bahlis, N. J., Song, K., White, D., Chen, C., Seftel, M. D., Howsen-Jan, K., Reece, D., Stewart, K., Xie, Y., Hay, A. E., Shepherd, L., Djurfeldt, M., Zhu, L., Meyer, R. M., Chen, B. E., & Reiman, T. (2016). A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma. Blood, 128(5), 732-735. https://doi.org/10.1182/blood-2016-06-716902

Han, M, Murugesan, A, Bahlis, NJ, Song, K, White, D, Chen, C, Seftel, MD, Howsen-Jan, K, Reece, D, Stewart, K, Xie, Y, Hay, AE, Shepherd, L, Djurfeldt, M, Zhu, L, Meyer, RM, Chen, BE & Reiman, T 2016, 'A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma', Blood, vol. 128, no. 5, pp. 732-735. https://doi.org/10.1182/blood-2016-06-716902

@article{5f0b2432dc79489893aba366c7d82d98,

title = "A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma",

author = "Ming Han and Alli Murugesan and Bahlis, {Nizar J.} and Kevin Song and Darrell White and Christine Chen and Seftel, {Matthew D.} and Kang Howsen-Jan and Donna Reece and Keith Stewart and Yagang Xie and Hay, {Annette E.} and Lois Shepherd and Marina Djurfeldt and Liting Zhu and Meyer, {Ralph M.} and Chen, {Bingshu E.} and Tony Reiman",

note = "Funding Information: This work was supported by a grant from Canada's Foundation for Innovation (T.R.). M.H. is supported by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by Dalhousie Medicine New Brunswick and Cancer Care Nova Scotia as part of The Terry Fox Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR).",

year = "2016",

month = aug,

day = "4",

doi = "10.1182/blood-2016-06-716902",

language = "English (US)",

volume = "128",

pages = "732--735",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "5",

}

TY - JOUR

T1 - A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

AU - Han, Ming

AU - Murugesan, Alli

AU - Bahlis, Nizar J.

AU - Song, Kevin

AU - White, Darrell

AU - Chen, Christine

AU - Seftel, Matthew D.

AU - Howsen-Jan, Kang

AU - Reece, Donna

AU - Stewart, Keith

AU - Xie, Yagang

AU - Hay, Annette E.

AU - Shepherd, Lois

AU - Djurfeldt, Marina

AU - Zhu, Liting

AU - Meyer, Ralph M.

AU - Chen, Bingshu E.

AU - Reiman, Tony

N1 - Funding Information: This work was supported by a grant from Canada's Foundation for Innovation (T.R.). M.H. is supported by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by Dalhousie Medicine New Brunswick and Cancer Care Nova Scotia as part of The Terry Fox Strategic Health Research Training Program in Cancer Research at the Canadian Institutes of Health Research (CIHR).

PY - 2016/8/4

Y1 - 2016/8/4

UR - http://www.scopus.com/inward/record.url?scp=84983009758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983009758&partnerID=8YFLogxK

U2 - 10.1182/blood-2016-06-716902

DO - 10.1182/blood-2016-06-716902

M3 - Letter

C2 - 27338095

AN - SCOPUS:84983009758

SN - 0006-4971

VL - 128

SP - 732

EP - 735

JO - Blood

JF - Blood

IS - 5

ER -

A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this